tadawul-
Element List Explanation
Introduction The Board of Directors of Jana Medical Company is pleased to invite its esteemed shareholders to participate and vote in the Ordinary General Assembly Meeting (First Meeting), which will be held, God willing, at 7:00 PM on Sunday, 29-07-1447 AH (corresponding to 18/01/2026 AD) – in person and via modern technology
City and Location of the General Assembly's Meeting The company's headquarters are in Riyadh – in person and via modern technology. (Using Tadawulaty system).
Company location:
https://maps.app.goo.gl/rYxieA1oMRofiPLF8
Hyperlink of the Meeting Location Click Here
Date of the General Assembly's Meeting 2026-01-18 Corresponding to 1447-07-29
Time of the General Assembly’s Meeting 19:00
Methodology of Convening the General Assembly’s Meeting Attendance in-person and via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End Shareholders who are registered in the issuers shareholders record at the Depositary Center by the end of the trade session prior to the general assembly meeting and in accordance with the laws and regulations. The shareholder has the right to delegate whomever other than the board of directors. The right to register a name to attend the general assembly meeting ends at the time of convening the general assembly meeting. The attendees right to vote on the items of the assembly’s agenda ends upon the end of screening the votes by the Screening Committee.
Quorum for Convening the General Assembly's Meeting The general assembly meeting (ordinary) shall be valid if attended by shareholders representing at least a quarter of the company’s capital with voting rights. If the quorum required to hold this meeting is not available, a second meeting shall be held one hour after the end of the period specified for holding the first meeting. In all cases, the second meeting shall be considered valid regardless of the number of shares with voting rights represented therein.
General Assembly Meeting Agenda 1. Voting on the appointment of the company's auditor from among the candidates, based on the recommendation of the Audit Committee, to examine, review, and audit the annual and semi-annual financial statements for the fiscal year 2025, and to determine their fees.
2. Voting on the Board of Directors' decision to appoint Mr. Ziyad bin Saleh Al-Sulais as an executive member of the Board, effective from his appointment date of November 22, 2025, to complete the current term ending on July 27, 2026, succeeding the former member, Mr. Fahd Mishal Al Ali, a non-executive member. (CV attached)
Proxy Form
The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right Shareholders have the right to discuss the topics listed in the
agenda of the General Assembly and raise relevant questions and inquiries. Shareholders can vote
remotely on the General Assembly Meeting’s agenda via (E-voting Service) of Tadawulaty, by clicking on the following link:
www.tadawulaty.com.sa
Details of the electronic voting on the Assembly’s agenda hareholders can vote remotely on the general assembly's agenda through the electronic voting service by visiting Tadawulaty's website www.tadawulaty.com.sa. Registration and voting are free for all shareholders. Electronic voting begins on Friday, 9 Jumada Al-Awwal 1447 (October 31, 2025), at 1:00 a.m., and ends at the conclusion of the general assembly.
Method of Communication in Case of Any Enquiries If you have any questions, please contact the Investor Relations Department at:
Phone: 00966112317685
Email:
info@janamd.com
Additional Information N/A
Attached Documents